Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Flu Ushers In Risky Claims Season

This article was originally published in The Tan Sheet

Executive Summary

Supplement firms are safest avoiding any mention of the flu, and trade groups see flu claims as a red flag for other problems. But flu season perennially brings in claims that skirt – or cross – the line, where they could draw fire from FDA.

You may also be interested in...



Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements

FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola.

Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements

FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola.

Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements

FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola. One firm’s website offers a video titled, “Urgent Message to Ebola-Stricken Nations' Heads of State,” and another claims “primary uses for oregano include athlete’s foot, candida, canker sores, Ebola virus.”

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel